---
schema_version: "secwatch.filing_event.v1"
accession: "0001214659-23-010804"
form_type: "8-K"
ticker: "ALZN"
cik: "0001677077"
company_name: "Alzamend Neuro, Inc."
filed_at: "2023-08-07T23:59:59+00:00"
generated_at: "2026-06-12T04:28:10.529399+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Alzamend Neuro receives Nasdaq delisting notice; hearing scheduled for Oct 12

## Summary
- Nasdaq notified Alzamend on Aug 1, 2023 it failed to regain compliance with $1 bid price rule.
- Company ineligible for second 180-day period due to not meeting $5M stockholders' equity initial listing requirement.
- Delisting was scheduled for Aug 10, 2023, but stay granted pending appeal to Nasdaq Hearings Panel.
- Hearing set for Oct 12, 2023; common stock continues trading under symbol ALZN during stay.
- Company has submitted required appeal by Aug 8, 2023 deadline.

## SEC filing metadata
- accession: 0001214659-23-010804
- form_type: 8-K
- ticker: ALZN
- cik: 0001677077
- company_name: Alzamend Neuro, Inc.
- filed_at: 2023-08-07T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1677077/000121465923010804/0001214659-23-010804-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1677077/000121465923010804/o872318k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001214659-23-010804
- JSON: https://secwatch.observer/filing/0001214659-23-010804.json
- Plain text: https://secwatch.observer/filing/0001214659-23-010804.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.